Utilisation du LASER vaginal pour le traitement des pathologies génito-urinaires : revue systématique de la littérature et position du CUROPF

2020, The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society, Menopause, 27, 976, 10.1097/GME.0000000000001609 Portman, 2014, Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society, Maturitas, 79, 349, 10.1016/j.maturitas.2014.07.013 Gambacciani, 2017, Laser therapy for the restoration of vaginal function, Maturitas, 99, 10, 10.1016/j.maturitas.2017.01.012 Gaspar, 2011, Vaginal fractional CO 2 laser: a minimally invasive option for vaginal rejuvenation, Am J Cosmet Surg, 28, 156, 10.1177/074880681102800309 FDA Warns Against Use of Energy-Based Devices to Perform Vaginal “Rejuvenation” or Vaginal Cosmetic Procedures: FDA Safety Communication. https://www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic. [Accessed September 1st, 2020]. Zerbinati, 2015, Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment, Lasers Med Sci, 30, 429, 10.1007/s10103-014-1677-2 Athanasiou, 2016, The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women, Climacteric J Int Menopause Soc, 19, 512, 10.1080/13697137.2016.1212006 Salvatore, 2014, A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study, Climacteric J Int Menopause Soc, 17, 363, 10.3109/13697137.2014.899347 Cruz, 2018, Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women, Menopause N Y N, 25, 21, 10.1097/GME.0000000000000955 Politano, 2019, Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial, Menopause N Y N, 26, 833, 10.1097/GME.0000000000001333 Samuels, 2019, Treatment to external labia and vaginal canal with CO2 laser for symptoms of vulvovaginal atrophy in postmenopausal women, Aesthet Surg J, 39, 83, 10.1093/asj/sjy087 Siliquini, 2017, Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women, Climacteric J Int Menopause Soc, 20, 379, 10.1080/13697137.2017.1319815 Marin, 2019, The results of new low dose fractional CO2 laser – A prospective clinical study in France, J Gynecol Obstet Hum Reprod Gambacciani, 2018, Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause, Climacteric J Int Menopause Soc, 21, 148, 10.1080/13697137.2018.1436538 Flint, 2019, Rationale and design for fractional microablative CO2 laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial, Climacteric J Int Menopause Soc, 22, 307, 10.1080/13697137.2018.1559806 Han, 2014, Association between pelvic organ prolapse and stress urinary incontinence with collagen, Exp Ther Med, 7, 1337, 10.3892/etm.2014.1563 Fistonić, 2016, Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women – a pilot study, Lasers Med Sci, 31, 635, 10.1007/s10103-016-1884-0 Tien, 2017, Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function, Int Urogynecology J, 28, 469, 10.1007/s00192-016-3129-y Pardo, 2016, Treatment of female stress urinary incontinence with Erbium-YAG laser in non-ablative mode, Eur J Obstet Gynecol Reprod Biol, 204, 1, 10.1016/j.ejogrb.2016.06.031 Lin, 2017, Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence, Taiwan J Obstet Gynecol, 56, 815, 10.1016/j.tjog.2017.10.020 Ogrinc, 2015, Novel minimally invasive laser treatment of urinary incontinence in women, Lasers Surg Med, 47, 689, 10.1002/lsm.22416 Gambacciani, 2015, Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause, Minerva Ginecol, 67, 97 Gambacciani, 2015, Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence, Climacteric J Int Menopause Soc, 18, 43, 10.3109/13697137.2015.1071608 Blaganje, 2018, Non-ablative Er: YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial, Eur J Obstet Gynecol Reprod Biol, 224, 153, 10.1016/j.ejogrb.2018.03.038 Lin, 2019, Effect of Er:YAG laser for women with stress urinary incontinence, BioMed Res Int, 2019, 7915813 Gaspar, 2018, Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study, Lasers Surg Med, 50, 802, 10.1002/lsm.22826 Okui, 2019, Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence, World J Urol, 37, 885, 10.1007/s00345-018-2445-x Pitsouni, 2016, Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study, Maturitas, 94, 131, 10.1016/j.maturitas.2016.09.012 Athanasiou, 2019, Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results, Menopause N Y N, 26, 248, 10.1097/GME.0000000000001206 González Isaza, 2018, Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause, Int Urogynecology J, 29, 211, 10.1007/s00192-017-3352-1 Behnia-Willison, 2019, Fractional CO2 laser for treatment of stress urinary incontinence, Eur J Obstet Gynecol Reprod Biol X, 1, 100004, 10.1016/j.eurox.2019.100004 Falguni, 2017, The effects of RF excited fractional CO2 laser on the vaginal canal in treating stress urinary incontinence, Obstet Gynecol, 129, 71S Perino, 2016, Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results, Eur Rev Med Pharmacol Sci, 20, 2491 Okui, 2019, Efficacy and safety of non-ablative vaginal erbium: YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists, World J Urol, 10.1007/s00345-019-02644-7 Tonyali, 2019, The utility of vaginal erbium: YAG laser in the treatment of overactive bladder syndrome is in need of confirmation, World J Urol Saito, 1999, Effect of ageing on blood flow to the bladder and bladder function, Urol Int, 62, 93, 10.1159/000030365 Andersson, 2017, The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction, Ther Adv Urol, 9, 11, 10.1177/1756287216675778 Bizjak-Ogrinc, 2013 Urska, 2017, Non-ablative vaginal erbium YAG laser for the treatment of cystocele, Ital J Gynaecol Obstet, 29, 19 Bizjak-Ogrinc, 2017, 3 years follow-up of pelvic organ prolapses treated with Er:YAG laser, Lasers Surg Med, 49 Gaviria, 2012, Laser vaginal tightening (LVT)–evaluation ofa novel noninvasive laser treatment for vaginal relaxation syndrome, J Laser Heal Acad Artic J LAHA, 2012, 59 Lee, 2014, Treatment of Vaginal relaxation syndrome with an erbium: YAG laser using 90° and 360° scanning scopes: a pilot study & short-term results, Laser Ther, 23, 129, 10.5978/islsm.14-OR-11 Sipos, 2019, The effect of fractional CO2 laser treatment on the symptoms of pelvic floor dysfunctions: pelvic floor distress inventory-20 questionnaire, Lasers Surg Med, 10.1002/lsm.23126 Athanasiou, 2020, Can pelvic organ prolapse in postmenopausal women be treated with laser therapy?, Climacteric, 24, 101, 10.1080/13697137.2020.1789092 Drumond, 2019, Case report: treatment for rectovaginal fistula in Crohn's disease using fractionate CO2 vaginal laser with anti-TNF therapy photobiomodulation, Photomed Laser Surg, 37, 451, 10.1089/photob.2019.4643 Filippini, 2019, Postpartum perineal pain: may the vaginal treatment with CO2 laser play a key-role in this challenging issue?, J Matern Fetal Neonatal Med, 1 Pagano, 2017, Evaluation of the CO<sub>2</sub> laser therapy on Vulvo-Vaginal Atrophy (VVA) in oncological patients: preliminary results, J Cancer Ther, 8, 452, 10.4236/jct.2017.85039 Pieralli, 2016, Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors, Arch Gynecol Obstet, 294, 841, 10.1007/s00404-016-4118-6 Arêas, 2019, The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: a prospective study, Menopause N Y N, 10.1097/GME.0000000000001353 Gordon, 2019, Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy, Menopause N Y N, 26, 423, 10.1097/GME.0000000000001293 Ahluwalia, 2019, Lasers and energy-based devices marketed for vaginal rejuvenation: a cross-sectional analysis of the MAUDE database, Lasers Surg Med, 10.1002/lsm.23084 Al-Badr, 2019, Laser vaginal tightening complications: report of three cases, Lasers Surg Med, 10.1002/lsm.23110 Walter, 2018, N o 358-traitement du syndrome génito-urinaire de la ménopause et de l’incontinence à l’effort par laser vaginal, J Obstet Gynaecol Can, 40, 512, 10.1016/j.jogc.2018.02.016 Song, 2018, The evidence for laser treatments to the vulvo-vagina: making sure we do not repeat past mistakes, Aust N Z J Obstet Gynaecol, 58, 148, 10.1111/ajo.12735 Shobeiri, 2019, IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity, Int Urogynecology J, 30, 371, 10.1007/s00192-018-3830-0 Tailor, 2019, Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories, Int Urogynecology J, 30, 1021, 10.1007/s00192-019-03959-0 Digesu, 2019, The energy based devices for vaginal “rejuvenation” urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: an international multidisciplinary expert panel opinion, Neurourol Urodyn, 38, 1005, 10.1002/nau.23927 Preti, 2019, The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS/ISSVD best practice consensus document, Neurourol Urodyn, 38, 1009, 10.1002/nau.23931 Escribano, 2019, In response to the FDA warning about the use of photomedicine in gynecology, Lasers Med Sci, 10.1007/s10103-019-02744-1 MedWatch: The FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program. [Accessed september 1st, 2020]. American Society of plastic surgeons. Non surgical female genital procedures. https://www.plasticsurgery.org/cosmetic-procedures/nonsurgical-vaginal-rejuvenation. [Accessed September 1st, 2020]. Katerina Mackova, 2020, Vaginal Er:YAG LASER application in the menopausal ewe model: a randomised oestrogen and sham controlled trial, BJOG